This page shows the latest Krystal Biotech news and features for those working in and with pharma, biotech and healthcare.
Following the news, the biotech’s shared dropped more than 20%, as investors became spooked by potential unfavourable results from the pivotal study. ... Krystal Biotech is also developing a candidate for RDEB – KB103 – and reported positive
Encouraging results for patients. Krystal Biotech has reported positive results from a mid-stage trial of its gene therapy for a life-threatening rare skin disease, and hopes to start a ... Encouragingly, Krystal’s data is the second piece of
More from news
Approximately 2 fully matching, plus 0 partially matching documents found.
ROAD is a digital PR and communications consultancy specialising in promoting the innovators that shape our future health and wellbeing....